一级婬片试看120分钟,安徽少妇BBBB搡BBBB,波多野结衣一级片

国产一级婬片A片免费无成人黑豆,亚洲AV无码乱码精品,黄色网址免费在线观看,少妇高潮久久久久久潘金莲

<tr id="cc0cc"></tr>

<nav id="cc0cc"></nav><small id="cc0cc"></small>

<sup id="cc0cc"></sup>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

国产一级婬乱片AV片AAA毛片 | 精品国偷自产国产一区 | 少妇搡bbbb搡bbb | 国产精品久久久久久久免费看 | 在线观看成年人网站污 | 无码人妻精品一区二区蜜桃在 | 无码国产69精品久久久久同性 | 西西4444WWW无码精品 | 国产裸体美女在线观看 | 亚洲精品乱码久久久久久蜜桃91 | 久久国产精品波多野结衣AV | 亚洲精品无码乱码成人果冻传媒 | 亚洲性爱视频在线观看 | 亚洲AV成人无码精品区 | 曰本丰满人妻熟妇BBBB | 国产成人污视频网站 | 特级西西人体WWWww | 沈阳户外少妇BBBB真爽 | 精品久久久久中文字幕人妻 | 人妻偷乱视频一区二区三区 | 精国产品一区二区三区A片 91麻豆产精品久久久久久 | 人妻少妇中文字幕 | 欧美人乱人精品A片 | 996久久在线热播 | 美女美乳摸摸日日夜夜 | 无码国产精品一区二区三 | 久久无码人妻一区二区三区午夜免费 | 四川少妇BBBBBB爽爽电影 | 3d动漫无码一区观看 | 影音先锋无码av在线 | 91国精产品一区二区三区 | 欧美婬片a片aaa毛片直播 | 日本中文字幕电影 | 少妇的肉体的满足毛片 | 亚洲高清无码中文视频 | 成人中字无码AV在线观看 | 91在线精品国产乱码一二三软件 | 中文字幕好色人妻av | 国产精品无码久久久久 | 91精品国产成人 | 搡老女人老太婆免费视 |

<tfoot id="ccccc"><dd id="ccccc"></dd></tfoot>

<nav id="ccccc"></nav>

<tr id="ccccc"></tr><tr id="ccccc"></tr>

<noscript id="ccccc"><dd id="ccccc"></dd></noscript>